Attitudes and experiences of community pharmacists towards paediatric off label prescribing: A prospective study

Derek Stewart, Abdul Rouf, Ailsa Claire Snaith, Kathleen Elliott, Peter Joseph Benedict Helms, James Stuart McLay

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

AIM: To identify community pharmacist experiences of, and attitudes towards paediatric off-label prescribing. METHODS: A prospective questionnaire-based study, with a 21-item questionnaire issued to 1500 randomly selected community pharmacies throughout the UK during 2005 on three separate occasions. RESULTS: Four hundred and eighty-two (32.1%) completed questionnaires were returned. Over 70% of respondents were familiar with the concept of off-label prescribing, primarily through dispensing experience rather than education, although only 40% were aware of having dispensed a paediatric off-label prescription within the previous month. The reasons given for a prescription being off label were younger age than recommended (84.6%, 297/351), primarily for antihistamines, analgesics and beta(2)-agonists, and higher (73.9%, 229/310) or lower than (41%, 103/258) recommended dose, primarily antibiotics and analgesics. Over 60% of respondents had been asked by the public to sell paediatric over-the-counter medicines, such as antihistamines, analgesics and steroid preparations for off-label use. The majority of respondents used the British National Formulary or the Pack Insert rather than specialist formularies or guidelines as a source of specialist paediatric information. Although 78% of respondents believed they had a responsibility to inform the prescriber that a medicine was off label, only 66% believed that they had a similar responsibility to inform parents. CONCLUSION: The community pharmacists who responded to this questionnaire appear to be aware of and concerned by the issues which surround paediatric off-label prescribing. Despite this, most gained relevant knowledge through work experience rather than undergraduate or postgraduate training or professional development.
Original languageEnglish
Pages (from-to)90-95
Number of pages6
JournalBritish Journal of Clinical Pharmacology
Volume64
Issue number1
Early online date23 Feb 2007
DOIs
Publication statusPublished - Jul 2007

Keywords

  • attitudes
  • community pharmacy
  • off-label prescribing
  • paediatrics
  • questionnaire
  • survey
  • adverse drug-reactions
  • children
  • wards

Cite this

Attitudes and experiences of community pharmacists towards paediatric off label prescribing : A prospective study. / Stewart, Derek; Rouf, Abdul; Snaith, Ailsa Claire; Elliott, Kathleen; Helms, Peter Joseph Benedict; McLay, James Stuart.

In: British Journal of Clinical Pharmacology, Vol. 64, No. 1, 07.2007, p. 90-95.

Research output: Contribution to journalArticle

Stewart, Derek ; Rouf, Abdul ; Snaith, Ailsa Claire ; Elliott, Kathleen ; Helms, Peter Joseph Benedict ; McLay, James Stuart. / Attitudes and experiences of community pharmacists towards paediatric off label prescribing : A prospective study. In: British Journal of Clinical Pharmacology. 2007 ; Vol. 64, No. 1. pp. 90-95.
@article{bec33069ce4e4fa987dcaf79ed1f51e6,
title = "Attitudes and experiences of community pharmacists towards paediatric off label prescribing: A prospective study",
abstract = "AIM: To identify community pharmacist experiences of, and attitudes towards paediatric off-label prescribing. METHODS: A prospective questionnaire-based study, with a 21-item questionnaire issued to 1500 randomly selected community pharmacies throughout the UK during 2005 on three separate occasions. RESULTS: Four hundred and eighty-two (32.1{\%}) completed questionnaires were returned. Over 70{\%} of respondents were familiar with the concept of off-label prescribing, primarily through dispensing experience rather than education, although only 40{\%} were aware of having dispensed a paediatric off-label prescription within the previous month. The reasons given for a prescription being off label were younger age than recommended (84.6{\%}, 297/351), primarily for antihistamines, analgesics and beta(2)-agonists, and higher (73.9{\%}, 229/310) or lower than (41{\%}, 103/258) recommended dose, primarily antibiotics and analgesics. Over 60{\%} of respondents had been asked by the public to sell paediatric over-the-counter medicines, such as antihistamines, analgesics and steroid preparations for off-label use. The majority of respondents used the British National Formulary or the Pack Insert rather than specialist formularies or guidelines as a source of specialist paediatric information. Although 78{\%} of respondents believed they had a responsibility to inform the prescriber that a medicine was off label, only 66{\%} believed that they had a similar responsibility to inform parents. CONCLUSION: The community pharmacists who responded to this questionnaire appear to be aware of and concerned by the issues which surround paediatric off-label prescribing. Despite this, most gained relevant knowledge through work experience rather than undergraduate or postgraduate training or professional development.",
keywords = "attitudes, community pharmacy, off-label prescribing, paediatrics, questionnaire, survey, adverse drug-reactions, children, wards",
author = "Derek Stewart and Abdul Rouf and Snaith, {Ailsa Claire} and Kathleen Elliott and Helms, {Peter Joseph Benedict} and McLay, {James Stuart}",
year = "2007",
month = "7",
doi = "10.1111/j.1365-2125.2007.02865.x",
language = "English",
volume = "64",
pages = "90--95",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Attitudes and experiences of community pharmacists towards paediatric off label prescribing

T2 - A prospective study

AU - Stewart, Derek

AU - Rouf, Abdul

AU - Snaith, Ailsa Claire

AU - Elliott, Kathleen

AU - Helms, Peter Joseph Benedict

AU - McLay, James Stuart

PY - 2007/7

Y1 - 2007/7

N2 - AIM: To identify community pharmacist experiences of, and attitudes towards paediatric off-label prescribing. METHODS: A prospective questionnaire-based study, with a 21-item questionnaire issued to 1500 randomly selected community pharmacies throughout the UK during 2005 on three separate occasions. RESULTS: Four hundred and eighty-two (32.1%) completed questionnaires were returned. Over 70% of respondents were familiar with the concept of off-label prescribing, primarily through dispensing experience rather than education, although only 40% were aware of having dispensed a paediatric off-label prescription within the previous month. The reasons given for a prescription being off label were younger age than recommended (84.6%, 297/351), primarily for antihistamines, analgesics and beta(2)-agonists, and higher (73.9%, 229/310) or lower than (41%, 103/258) recommended dose, primarily antibiotics and analgesics. Over 60% of respondents had been asked by the public to sell paediatric over-the-counter medicines, such as antihistamines, analgesics and steroid preparations for off-label use. The majority of respondents used the British National Formulary or the Pack Insert rather than specialist formularies or guidelines as a source of specialist paediatric information. Although 78% of respondents believed they had a responsibility to inform the prescriber that a medicine was off label, only 66% believed that they had a similar responsibility to inform parents. CONCLUSION: The community pharmacists who responded to this questionnaire appear to be aware of and concerned by the issues which surround paediatric off-label prescribing. Despite this, most gained relevant knowledge through work experience rather than undergraduate or postgraduate training or professional development.

AB - AIM: To identify community pharmacist experiences of, and attitudes towards paediatric off-label prescribing. METHODS: A prospective questionnaire-based study, with a 21-item questionnaire issued to 1500 randomly selected community pharmacies throughout the UK during 2005 on three separate occasions. RESULTS: Four hundred and eighty-two (32.1%) completed questionnaires were returned. Over 70% of respondents were familiar with the concept of off-label prescribing, primarily through dispensing experience rather than education, although only 40% were aware of having dispensed a paediatric off-label prescription within the previous month. The reasons given for a prescription being off label were younger age than recommended (84.6%, 297/351), primarily for antihistamines, analgesics and beta(2)-agonists, and higher (73.9%, 229/310) or lower than (41%, 103/258) recommended dose, primarily antibiotics and analgesics. Over 60% of respondents had been asked by the public to sell paediatric over-the-counter medicines, such as antihistamines, analgesics and steroid preparations for off-label use. The majority of respondents used the British National Formulary or the Pack Insert rather than specialist formularies or guidelines as a source of specialist paediatric information. Although 78% of respondents believed they had a responsibility to inform the prescriber that a medicine was off label, only 66% believed that they had a similar responsibility to inform parents. CONCLUSION: The community pharmacists who responded to this questionnaire appear to be aware of and concerned by the issues which surround paediatric off-label prescribing. Despite this, most gained relevant knowledge through work experience rather than undergraduate or postgraduate training or professional development.

KW - attitudes

KW - community pharmacy

KW - off-label prescribing

KW - paediatrics

KW - questionnaire

KW - survey

KW - adverse drug-reactions

KW - children

KW - wards

U2 - 10.1111/j.1365-2125.2007.02865.x

DO - 10.1111/j.1365-2125.2007.02865.x

M3 - Article

VL - 64

SP - 90

EP - 95

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 1

ER -